Aarey Drugs & Pharm Ltd
₹98.89
+3.32%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.33.
- Promoters hold a sizeable stake (42.79%).
!Watch-points
- Thin interest cover: operating profit covers interest only about 1.4 times.
- Return on equity is on the lower side at 2.8%.
- Return on capital employed is on the lower side at 5.6%.
- Net profit margin is slim at 0.9%.
- Profit growth has been slow over five years (about -9% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.86
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 330 Cr
Current Price₹ 98.89
High / Low₹ 101.29 / 50.31
Stock P/E76.65892
Book Value₹ 53.00
Dividend Yield0%
ROCE5.58%
ROE2.75%
Face Value₹ 10.00
Debt to Equity0.33
PEG Ratio—
EV / EBITDA35.50
Industry PE35.70
P/B Ratio1.8706138
EPS₹ 1.40
Debt₹ 50 Cr
PAT Margin0.85%
Cash PAT₹ 7 Cr
ICR1.40
Promoter Holding42.79%
FII Holding4.41%
DII Holding1.49%
Public Holding51.31%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity